K-numberK250185
Device nameElectronic Sphygmomanometers (ZH-X9, ZH-X12, ZH-X16, ZH-X17, ZH-X18, ZH-X19, ZH-X23, ZH-X24)
ApplicantJiangxi Aicare Medical Technology Co., Ltd.
Product codeDXN
Device classClass II
Decision dateJul 14, 2025
DecisionSubstantially Equivalent
Regulation870.1130
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Electronic Sphygmomanometers (models ZH-X9, ZH-X12, ZH-X16, ZH-X17, ZH-X18, ZH-X19, ZH-X23, ZH-X24) are automated, non-invasive blood pressure monitors intended to measure systolic and diastolic pressure in adults and adolescents aged 18–21 years for home use. The device is contraindicated in pregnant women, including those with preeclampsia.

Technological characteristics

The proposed device uses oscillometric measurement with arm circumference range 22–42 cm, pressure accuracy of ±3 mmHg (±0.4 kPa) or 2% of reading, and LCD display with mmHg/kPa unit selection. It stores 2×99 sets of measurement data, operates on 4 AAA batteries (DC 6V) or optional USB adapter, and includes optional Bluetooth transmission capability. The predicate device has similar specifications but narrower cuff range (22–32 cm) and lacks Bluetooth.

Test standards cited

IEC 80601-2-30 (automated non-invasive sphygmomanometers), ISO 81060-2 (clinical validation of automated measurement type), ANSI AAMI ES 60601-1, IEC 60601-1-2 (electromagnetic disturbances), IEC 60601-1-11 (home healthcare environment), ISO 10993-5/-10/-23 (biocompatibility), and FCC Part 15 Subpart C (RF emissions).

Substantial equivalence argument

The proposed device and predicate (K191894) share identical intended use, oscillometric measurement principle, accuracy specifications, display type, memory function, and general operating environment parameters. Although the proposed device has a wider cuff circumference range (22–42 cm vs. 22–32 cm), optional Bluetooth capability, and modified appearance across seven models, the applicant demonstrates these differences fall within the scope of existing cleared reference devices and do not affect safety or effectiveness. Comparative clinical testing per ISO 81060-2 showed significant correlation between the proposed and predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →